Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Late-Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor-Induced Raynaud's-Like Phenomenon.
Khan S, von Itzstein MS, Lu R, Bermas BL, Karp DR, Khan SA, Fattah FJ, Park JY, Saltarski JM, Gloria-McCutchen Y, Xie Y, Li QZ, Wakeland EK, Gerber DE. Khan S, et al. Among authors: saltarski jm. Oncologist. 2020 May;25(5):e753-e757. doi: 10.1634/theoncologist.2019-0666. Epub 2020 Mar 13. Oncologist. 2020. PMID: 32167195 Free PMC article.
Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A "Two-Hit" Autoimmune Toxicity or Clinical Predisposition?
von Itzstein MS, Khan S, Popat V, Lu R, Khan SA, Fattah FJ, Park JY, Bermas BL, Karp DR, Ahmed M, Saltarski JM, Gloria-McCutchen Y, Xie Y, Li QZ, Wakeland EK, Gerber DE. von Itzstein MS, et al. Among authors: saltarski jm. Oncologist. 2020 Aug;25(8):e1242-e1245. doi: 10.1634/theoncologist.2019-0911. Epub 2020 Jun 3. Oncologist. 2020. PMID: 32400023 Free PMC article.
Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors.
Ahmed M, von Itzstein MS, Sheffield T, Khan S, Fattah F, Park JY, Popat V, Saltarski JM, Gloria-McCutchen Y, Hsiehchen D, Ostmeyer J, Khan SA, Sultana N, Xie Y, Li QZ, Wakeland EK, Gerber DE. Ahmed M, et al. Among authors: saltarski jm. J Immunother Cancer. 2021 Jun;9(6):e002349. doi: 10.1136/jitc-2021-002349. J Immunother Cancer. 2021. PMID: 34127546 Free PMC article.
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy.
von Itzstein MS, Gonugunta AS, Sheffield T, Homsi J, Dowell JE, Koh AY, Raj P, Fattah F, Wang Y, Basava VS, Khan S, Park JY, Popat V, Saltarski JM, Gloria-McCutchen Y, Hsiehchen D, Ostmeyer J, Xie Y, Li QZ, Wakeland EK, Gerber DE. von Itzstein MS, et al. Among authors: saltarski jm. Cancers (Basel). 2022 Mar 4;14(5):1327. doi: 10.3390/cancers14051327. Cancers (Basel). 2022. PMID: 35267634 Free PMC article.
Therapeutic Targeting of Nuclear Export Inhibition in Lung Cancer.
Gupta A, Saltarski JM, White MA, Scaglioni PP, Gerber DE. Gupta A, et al. Among authors: saltarski jm. J Thorac Oncol. 2017 Sep;12(9):1446-1450. doi: 10.1016/j.jtho.2017.06.013. Epub 2017 Jun 21. J Thorac Oncol. 2017. PMID: 28647672 Free PMC article. Review.
Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer.
Gerber DE, Putnam WC, Fattah FJ, Kernstine KH, Brekken RA, Pedrosa I, Skelton R, Saltarski JM, Lenkinski RE, Leff RD, Ahn C, Padmanabhan C, Chembukar V, Kasiri S, Kallem RR, Subramaniyan I, Yuan Q, Do QN, Xi Y, Reznik SI, Pelosof L, Faubert B, DeBerardinis RJ, Kim J. Gerber DE, et al. Among authors: saltarski jm. Clin Cancer Res. 2020 Nov 15;26(22):6017-6027. doi: 10.1158/1078-0432.CCR-20-1916. Epub 2020 Aug 26. Clin Cancer Res. 2020. PMID: 32847935 Free PMC article. Clinical Trial.